YuanBio Venture Capital

Activity in this selectionutokyo-innovation-platform-co-30b7fd61

By stage

Series A2

Series C+1

Biotech3

United States2

China1

3 in this selection

Aug 27

Develops oligonucleotide therapeutics targeting chronic hepatitis B

$120MSeries C

Role not disclosed

Aug 12

AI-driven drug discovery company using its ExCEED molecular design platform

$30MSeries A

Role not disclosed

Jul 28

Developing the next generation of precision medicines by going beyond genomics.

$21MSeries A

Role not disclosed